
Certara.AI Page
Use Certara’s AI platform for Life Sciences to solve data silo problems while improving analytics capabilities that boost productivity.
Use Certara’s AI platform for Life Sciences to solve data silo problems while improving analytics capabilities that boost productivity.
We look at the role of non-CRF data in clinical trials, and best practices for handling this type of data, including robust Data Transfer Specifications.
SDTM mapping can be one of the most challenging programming problems in a clinical trial build. It involves mapping datasets from a non-CDISC structure, for example the structure used in…
We touched on the SDTM supplemental qualifier in the SDTM mapping process simplified. In this blog, we’ll delve deeper into this subject with detailed examples. So, what are SDTM supplemental…
With nine FDA-approved drugs today, 100+ in clinical development and several hundred in the preclinical stage, the market for bispecific antibodies is projected to grow to >$30B by 2028. The…
A comprehensive guide to optimizing early development strategies.
Abstract This poster features a collaboration between Applied BioMath and Genmab and was first presented at SITC 2021. Applied BioMath was acquired by Certara in December 2023.